Regeneron files Eylea(VEGF TRAP-EYE) at FDA for CRVO - 24-Feb-2012
Based on the results of the GALILEO study and one otherstudy Regeneron Pharmaceuticals, has submitted a supplemental Biologics License Application (sBLA) in the US for the CRVO indication and has been granted an FDA action date of 23 September 2012.
Related News
FDA approves Eylea (Regeneron) for Macular Oedema following Central Retinal Vein Occlusion
Regeneron files Eylea(VEGF TRAP-EYE) at FDA for CRVO
Results positive for Afinitor (Novartis) in BOLERO-3 study in HER2 positive Breast Cancer
Study of Prolia (Amgen/GSK) plus teriparatide shows significant benefits in Osteoporosis
SAR 302503 (Sanofi) successs in JAKARTA study of Myelofibrosis
Phase III study of NEPA (Helsinn and Eisai) meets endpoint in patients with Nausea
Phase III study of Tomtovok (Boehringer) meets endpoint for NSCLC
IDMC halts Phase III study of Vargatef (Boehringer) in NSCLC
Related Eye Health and Disorders Information
Eye Health and Disorders Clinical Guidelines
Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension
NICEEye Health and Disorders Medical Journal Abstracts
Efficacy and safety of collagen matrix implants in phacotrabeculectomy, and comparison with mitomycin C augmented phacotrabeculetcomy at one year
Clinical & Experimental Ophthalmology 25 December 2012Is pre-operative ciliary body and iris anatomical configuration a predictor of malignant glaucoma development?
Clinical & Experimental Ophthalmology 25 December 2012Eye Health and Disorders Medical Apps
Clinical and experimental Opthalmology
Free
Eye Handbook
Free
Related Eye Health and Disorders Drugs
- EMADINE 0.05% W/V, EYE DROPS, SOLUTION
- PILOCARPINE HYDROCHLORIDE
- BETAGAN
- VOLTAROL OPHTHA MULTIDOSE 0.1% EYE DROPS
- MINIMS CYCLOPENTOLATE HYDROCHLORIDE
- XALATAN
- FUCITHALMIC
- POLYTRIM
- ISOPTO PLAIN
- VISCOTEARS LIQUID GEL
- MAXIDEX
- HYPROMELLOSE EYE DROPS BP
- VISUDYNE 15 MG, POWDER FOR SOLUTION FOR INFUSION
- VOTRIENT 200 MG AND 400 MG FILM COATED TABLETS
- GELTEARS
- EYLEA 40MG/ML SOLUTION FOR INJECTION IN A VIAL
- MOXIVIG 0.5%W/V EYE DROPS, SOLUTION
- PHENYLEPHRINE EYE DROPS
- VOTRIENT 200 MG FILM-COATED TABLETS
- NEOSPORIN
- NEOMYCIN (EYE)
- OCULOTECT
- LUMIGAN EYE DROPS
- MYDRILATE
- FLUORETS
- VOTRIENT 200 MG FILM-COATED TABLETS
- MYDRIACYL 1%
- DIAMOX SODIUM 500MG POWDER FOR SOLUTION FOR INJECTION
- SOFRAMYCIN
- TRUSOPT
- MAXITROL OINTMENT
- POLYFAX OINTMENT
- VOLTAROL OPHTHA (INFLAMMATION)
- DUOTRAV EYE DROPS
- LACRI-LUBE
- IOPIDINE
- OPTILAST
- CHLOROMYTOL 0.5% W/V EYE DROPS
- MINIMS ATROPINE SULPHATE
- CHLOROMYCETIN
- CELLUVISC
- CILOXAN 3MG/G EYE OINTMENT
- BROCHLOR EYE DROPS
- MINIMS DEXAMETHASONE SODIUM PHOSPHATE 0.1% W/V, EYE DROPOS SOLUTION
- PROPINE
- COMBIGAN SOLUTION
- ZOVIRAX EYE OINTMENT
- ACULAR
- VEXOL 1% EYE DROPS, SUSPENSION
- MINIMS ARTIFICIAL TEARS
- DIAMOX TABLETS 250MG
- TEOPTIC 1% - TEOPTIC 2%
- ARTELAC SDU
- RAPITIL
- IOCARE
- OCUFEN
- LUBRI-TEARS
- MINIMS CHLORAMPHENICOL
- TOBRADEX
- AZOPT
- VIRGAN
- ISOPTO ALKALINE
- MACUGEN
- FML
- TIMOLOL
- LIQUIFILM TEARS
- ALPHAGAN
- DORZOLAMIDE/TIMOLOL 20MG/ML + 5MG/ML EYE DROPS, SOLUTION
- PRED FORTE
- OTRIVINE-ANTISTIN
- OPTICROM
- ILUBE
- HOMATROPINE
- OZURDEX
- CILOXAN 0.3% W/V EYE DROPS, SOLUTION
- COSOPT PRESERVATIVE-FREE, SINGLE DOSE EYE DROPS
- ALOMIDE 0.1% W/V
- ATROPINE (GENERIC-EYE)
- CHLORAMPHENICOL EYE DROPS & OINTMENT
- BETOPTIC
- LUCENTIS 10 MG/ML SOLUTION FOR INJECTION
- EXOCIN
Advert for Healthcare Professionals only